OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Control of the activity of CAR-T cells within tumours via focused ultrasound
Yiqian Wu, Yahan Liu, Ziliang Huang, et al.
Nature Biomedical Engineering (2021) Vol. 5, Iss. 11, pp. 1336-1347
Open Access | Times Cited: 143

Showing 1-25 of 143 citing articles:

CAR immune cells: design principles, resistance and the next generation
Louai Labanieh, Crystal L. Mackall
Nature (2023) Vol. 614, Iss. 7949, pp. 635-648
Closed Access | Times Cited: 339

Overcoming on-target, off-tumour toxicity of CAR T cell therapy for solid tumours
Christian Flugel, Robbie G. Majzner, Giedre Krenciute, et al.
Nature Reviews Clinical Oncology (2022) Vol. 20, Iss. 1, pp. 49-62
Open Access | Times Cited: 243

Spatiotemporal control of engineered bacteria to express interferon-γ by focused ultrasound for tumor immunotherapy
Yuhao Chen, Meng Du, Zhen Yuan, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 119

The future of engineered immune cell therapies
Darrell J. Irvine, Marcela V. Maus, David Mooney, et al.
Science (2022) Vol. 378, Iss. 6622, pp. 853-858
Open Access | Times Cited: 118

Modular-designed engineered bacteria for precision tumor immunotherapy via spatiotemporal manipulation by magnetic field
Xiaotu Ma, Xiaolong Liang, Yao Li, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 113

Rational Design of Biomaterials to Potentiate Cancer Thermal Therapy
Yujie Zhu, Quguang Li, Chunjie Wang, et al.
Chemical Reviews (2023) Vol. 123, Iss. 11, pp. 7326-7378
Closed Access | Times Cited: 92

The evolution of synthetic receptor systems
Janvie Manhas, Hailey I. Edelstein, Joshua N. Leonard, et al.
Nature Chemical Biology (2022) Vol. 18, Iss. 3, pp. 244-255
Open Access | Times Cited: 80

Applications of focused ultrasound-mediated blood-brain barrier opening
Catherine M. Gorick, Victoria R. Breza, Katherine M. Nowak, et al.
Advanced Drug Delivery Reviews (2022) Vol. 191, pp. 114583-114583
Open Access | Times Cited: 77

CAR T Cell Therapy in Primary Brain Tumors: Current Investigations and the Future
Ya-Jui Lin, Leila A. Mashouf, Michael Lim
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 74

In-vivo programmable acoustic manipulation of genetically engineered bacteria
Ye Yang, Yaozhang Yang, Dingyuan Liu, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 53

Extracellular Matrix Viscosity Reprogramming by In Situ Au Bioreactor-Boosted Microwavegenetics Disables Tumor Escape in CAR-T Immunotherapy
Duo Wang, Mengqi Zhang, Guanhua Qiu, et al.
ACS Nano (2023) Vol. 17, Iss. 6, pp. 5503-5516
Closed Access | Times Cited: 44

Enhancing the safety of CAR-T cell therapy: Synthetic genetic switch for spatiotemporal control
Li Lu, Mingqi Xie, Bo Yang, et al.
Science Advances (2024) Vol. 10, Iss. 8
Open Access | Times Cited: 20

Lymph node-biomimetic scaffold boosts CAR-T therapy against solid tumor
Ziyan Liao, Jie Jiang, Wei Wu, et al.
National Science Review (2024) Vol. 11, Iss. 4
Open Access | Times Cited: 19

Novel strategies to manage CAR-T cell toxicity
Arthur Mulvey, Lionel Trueb, George Coukos, et al.
Nature Reviews Drug Discovery (2025)
Closed Access | Times Cited: 4

A temperature-inducible protein module for control of mammalian cell fate
William Benman, Zikang Huang, Pavan Iyengar, et al.
Nature Methods (2025)
Closed Access | Times Cited: 2

Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasound
Scott Schoen, M. Sait Kilinc, Hohyun Lee, et al.
Advanced Drug Delivery Reviews (2021) Vol. 180, pp. 114043-114043
Open Access | Times Cited: 73

Intraparticle Double‐Scattering‐Decoded Sonogenetics for Augmenting Immune Checkpoint Blockade and CAR‐T Therapy
Duo Wang, Mengqi Zhang, Yan Zhang, et al.
Advanced Science (2022) Vol. 9, Iss. 32
Open Access | Times Cited: 51

Biophysics in tumor growth and progression: from single mechano-sensitive molecules to mechanomedicine
Ying Xin, Keming Li, Miao Huang, et al.
Oncogene (2023) Vol. 42, Iss. 47, pp. 3457-3490
Open Access | Times Cited: 40

Modulating tumor physical microenvironment for fueling CAR-T cell therapy
Zhong Luo, Xuemei Yao, Menghuan Li, et al.
Advanced Drug Delivery Reviews (2022) Vol. 185, pp. 114301-114301
Closed Access | Times Cited: 39

A Phase Engineering Strategy of Perovskite‐Type ZnSnO3:Nd for Boosting the Sonodynamic Therapy Performance
Rui Zhang, Pengyu Zang, Dan Yang, et al.
Advanced Functional Materials (2023) Vol. 33, Iss. 25
Closed Access | Times Cited: 25

Sonogenetics for Monitoring and Modulating Biomolecular Function by Ultrasound
Johannes Hahmann, Aman Ishaqat, Twan Lammers, et al.
Angewandte Chemie International Edition (2024) Vol. 63, Iss. 13
Open Access | Times Cited: 13

Sonogenetics-controlled synthetic designer cells for cancer therapy in tumor mouse models
Tian Gao, Lingxue Niu, Xin Wu, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101513-101513
Open Access | Times Cited: 12

CAR‐T‐cell products in solid tumors: Progress, challenges, and strategies
Kewen Qian, Guangyao Li, Shuyi Zhang, et al.
Deleted Journal (2024) Vol. 2, Iss. 2
Open Access | Times Cited: 10

Recurrent Glioblastoma—Molecular Underpinnings and Evolving Treatment Paradigms
Christopher Chang, Velina Chavarro, Jakob V. E. Gerstl, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6733-6733
Open Access | Times Cited: 10

Page 1 - Next Page

Scroll to top